Delivery Order SPE2DB20D3103-SPE2DB24FP2F9
Award Date
6/18/24
Potential Completion Date
6/20/24
Potential Value
$3.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,989.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. This contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of July 17, 2024. The contract is not designated as a set-aside....
This federal contract award, valued at $3,341.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a prescription medication used to treat diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of December 5, 2024. The contract was not designated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a ceiling value of $3,003.00 and a completion date of March 6, 2025. This appears to be a delivery order contract with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $13,211.45, is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 29, 2024. The contract is not designated with a set-aside. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,008.48 firm-fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to treat diabetes. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP03S, is a delivery order issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has a ceiling value of $5,635.34 and a completion date of April 23, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,730.66, is a delivery order for the procurement of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 26, 2024 and a pricing type of firm fixed price. This contract is not designated as a set-aside...
The federal contract award, valued at $4,693.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order contract is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used in the management of diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,213.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of diabetes. This contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 4, 2025. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,293.51 firm fixed-price delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a medication used to manage diabetes. The contract has an ultimate completion date of March 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...